Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts

Journal of Experimental Medicine

Volumn 196, Issue 10, 2002, Pages 1321-1333

  Minamoto, Kanji ^a   Pinsky, David J ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia University ^*  (United States)

Author keywords

Allograft; Apoptosis; Lung transplantation; Nitric oxide synthase; Obliterative bronchitis

Indexed keywords

ANTIBIOTIC AGENT; CD3 ANTIGEN; CD8 ANTIGEN; CEFAZOLIN; CHEMOKINE; CYCLOSPORIN; CYTOKINE; ISOENZYME; NITRIC OXIDE SYNTHASE;

AIRWAY OBSTRUCTION; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; ENDOTHELIUM; GRAFT REJECTION; HEART; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTIMA; ISOGRAFT; LEUKOCYTE; LUNG TRANSPLANTATION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OCCLUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; T LYMPHOCYTE; TISSUE GRAFT; TRACHEA; VASCULAR DISEASE; WILD TYPE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CHEMOKINES; DNA PRIMERS; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER; TRACHEA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037131986     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20012135     Document Type: Article

References (60)

1. Berry, G.J., E.M. Brunt, D. Chamberlain, R.H. Hruban, R.K. Sibley, S. Stewart, and H.D. Tazelaar. 1990. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung rejection study group. J. Heart Transplant. 9:593-601.
2. Trulock, E.P. 1997. Lung transplantation. Am. J. Respir. Crit. Care Med. 155:789-818.
3. Hruban, R.H., W.E. Beschorner, W.A. Baumgartner, S.C. Achuff, T.A. Traill, B.R. Marsh, P.K. Gupta, G.M. Hutchins, and B.A. Reitz. 1988. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. J. Thorac. Cardiovasc. Surg. 96:939-946.
4. Yousem, S.A. 1993. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am. J. Surg. Pathol. 17:491-496.
5. Yousem, S.A., G.J. Berry, P.T. Cagle, D. Chamberlain, A.N. Husain, R.H. Hruban, A. Marchevsky, N.P. Ohori, J. Ritter, S. Stewart, et al. 1996. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group. J. Heart Lung Transplant. 15:1-15.
6. Grasemann, H., N. Knauer, R. Buscher, K. Hubner, J.M. Drazen, and F. Ratjen. 2000. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am. J. Respir. Crit. Care Med. 162:2172-2176.
7. Guo, F.H., H.R. De Raeve, T.W. Rice, D.J. Stuehr, F.B. Thunnissen, and S.C. Erzurum. 1995. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. USA. 92: 7809-7813.
8. Giaid, A., and D. Saleh. 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333:214-221.
9. McDermott, C.D., S.M. Gavita, H. Shennib, and A. Giaid. 1997. Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis. Transplantation. 64:270-274.
10. Gabbay, E., E.H. Walters, B. Orsida, H. Whitford, C. Ward, T.C. Kotsimbos, G.I. Snell, and T.J. Williams. 2000. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 162:2182-2187.
11. Mason, N.A., D.R. Springall, A. Pomerance, T.J. Evans, M.H. Yacoub, and J.M. Polak. 1998. Expression of inducible nitric oxide synthase and formation of peroxynitrite in post-transplant obliterative bronchiolitis. J. Heart Lung Transplant. 17:710-714.
12. Beckman, J.S., T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87: 1620-1624.
13. Albina, J.E., S. Cui, R.B. Mateo, and J.S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:5080-5085.
14. Pinsky, D.J., B. Cai, X. Yang, C. Rodriguez, R.R. Sciacca, and P.J. Cannon. 1995. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J. Clin. Invest. 95:677-685.
15. Pinsky, D.J., W. Aji, M. Szabolcs, E.S. Athan, Y. Liu, Y.M. Yang, K.P. Kline, K.E. Olson, and P.J. Cannon. 1999. Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. Am. J. Physiol. 277:H1189-H1199.
16. + T cells surrounding Plasmodium berghei-infected hepatocytes. Infect. Immun. 65:3882-3888.
17. Asano, K., C.B. Chee, B. Gaston, C.M. Lilly, C. Gerard, J.M. Drazen, and J.S. Stamler. 1994. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. USA. 91:10089-10093.
18. Trifilieff, A., Y. Fujitani, F. Mentz, B. Dugas, M. Fuentes, and C. Bertrand. 2000. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J. Immunol. 165:1526-1533.
19. Belperio, J.A., M.D. Burdick, M.P. Keane, Y.Y. Xue, J.P. Lynch, B.L. Daugherty, S.L. Kunkel, and R.M. Strieter. 2000. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J. Immunol. 165:461-472.
20. Kelley, J. 1990. Cytokines of the lung. Am. Rev. Respir. Dis. 141:765-788.
21. Zhang, H.Y., M. Gharaee-Kermani, and S.H. Phan. 1997. Regulation of lung fibroblast α-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1β. J. Immunol. 158:1392-1399.
22. Messmer, U.K., and B. Brüne. 1996. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem. J. 319:299-305.
23. -/- recipients correlates with reduced apoptosis. Circulation. 99:836-842.
24. Russell, M.E., D.H. Adams, L.R. Wyner, Y. Yamashita, N.J. Halnon, and M.J. Karnovsky. 1993. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc. Natl. Acad. Sci. USA. 90:6086-6090.
25. Fairchild, R.L., A.M. VanBuskirk, T. Kondo, M.E. Wakely, and C.G. Orosz. 1997. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation. 63:1807-1812.
26. Qian, S., L. Lu, F. Fu, Y. Li, W. Li, T.E. Starzl, J.J. Fung, and A.W. Thomson. 1997. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J. Immunol. 158:4654-4661.
27. Kabelitz, D. 1998. Apoptosis, graft rejection, and transplantation tolerance. Transplantation. 65:869-875.
28. Russell, M.E., A.F. Wallace, L.R. Wyner, J.B. Newell, and M.J. Karnovsky. 1995. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 92:457-464.
29. Worrall, N.K., W.D. Lazenby, T.P. Misko, T.S. Lin, C.P. Rodi, P.T. Manning, R.G. Tilton, J.R. Williamson, and T.B. Ferguson, Jr. 1995. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181:63-70.
30. Koglin, J., T. Glysing-Jensen, J.S. Mudgett, and M.E. Russell. 1998. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation. 97:2059-2065.
31. Kallio, E.A., P.K. Koskinen, E. Aavik, K. Vaali, and K.B. Lemstöm. 1997. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. J. Clin. Invest. 100:2984-2994.
32. Szabolcs, M., R.E. Michler, X. Yang, W. Aji, D. Roy, E. Athan, R.R. Sciacca, O.P. Minanov, and P.J. Cannon. 1996. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation. 94:1665-1673.
33. Szabolcs, M.J., S. Ravalli, O. Minanov, R.R. Sciacca, R.E. Michler, and P.J. Cannon. 1998. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation. 65:804-812.
34. August, C., K.W. Schmid, K.H. Dietl, and S. Heidenreich. 1999. Prognostic value of lymphocyte apoptosis in acute rejection of renal allografts. Transplantation. 67:581-585.
35. Afford, S.C., S. Hubscher, A.J. Strain, D.H. Adams, and J.M. Neuberger. 1995. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J. Pathol. 176:373-380.
36. Russell, J.H. 1995. Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7:382-388.
37. Ullrich, R., K.D. Bloch, F. Ichinose, W. Steudel, and W.M. Zapol. 1999. Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice. J. Clin. Invest. 104:1421-1429.
38. Lane, B.P., G.S. Habicht, and G.S. Jasper. 1977. Lymphocyte-epithelium interaction during rejection of nonisogeneic rat tracheal grafts. Am. J. Pathol. 86:71-80.
39. Hertz, M.I., J. Jessurun, M.B. King, S.K. Savik, and J.J. Murray. 1993. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am. J. Pathol. 142:1945-1951.
40. - Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J. Immunol. 168:3493-3501.
41. Okada, K., T. Fujita, K. Minamoto, H. Liao, Y. Naka, and D.J. Pinsky. 2000. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J. Biol. Chem. 275: 21468-21476.
42. Ashkenazi, A., and V.M. Dixit. 1998. Death receptors: Signaling and modulation. Science. 281:1305-1308.
43. Tewari, M., D.R. Beidler, and V.M. Dixit. 1995. CrmA-inhibitable cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270:18738-18741.
44. Saltzman, A., R. Munro, G. Searfoss, C. Franks, M. Jaye, and Y. Ivashchenko. 1998. Transforming growth factor-β-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Exp. Cell Res. 242:244-254.
45. Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg, and M.E. Peter. 1998. Apoptosis signaling by death receptors. Eur. J. Biochem. 254:439-459.
46. Crow, J.P., and J.S. Beckman. 1995. Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv. Pharmacol. 34:17-43.
47. De Andrade, J.A., J.P. Crow, L. Viera, C. Bruce Alexander, K. Randall Young, D.C. McGiffin, G.L. Zorn, S. Zhu, S. Matalon, and R.M. Jackson. 2000. Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts. Am. J. Respir. Crit. Care Med. 161:2035-2042.
48. Ibrahim, L., M. Dominguez, and M. Yacoub. 1993. Primary human adult lung epithelial cells in vitro: Response to interferon-gamma and cytomegalovirus. Immunology. 79: 119-124.
49. Ohori, N.P., A.T. Iacono, W.F. Grgurich, and S.A. Yousem. 1994. Significance of acute bronchitis/bronchiolitis in the lung transplant recipient. Am. J. Surg. Pathol. 18:1192-1204.
50. Fisher, A.J., E. Gabbay, T. Small, S. Doig, J.H. Dark, and P.A. Corris. 1998. Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax. 53:454-458.
51. De Caterina, R., P. Libby, H.B. Peng, V.J. Thannickal, T.B. Rajavashisth, M.A. Gimbrone, Jr., W.S. Shin, and J.K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60-68.
52. Tsao, P.S., B. Wang, R. Buitrago, J.Y. Shyy, and J.P. Cooke. 1997. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 96:934-940.
53. Clancy, R.M., J. Leszczynska-Piziak, and S.B. Abramson. 1992. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90:1116-1121.
54. Lega, M., J.H. Dauber, S.E. Urch, R. Banas, T.L. Whiteside, and B.P. Griffith. 1992. Tumor necrosis factor-alpha production by alveolar macrophages in heart-lung transplant recipients. Am. Rev. Respir. Dis. 145:1036-1041.
55. Monti, G., A. Magnan, M. Fattal, B. Rain, M. Humbert, J.L. Mege, M. Noirclerc, P. Dartevelle, J. Cerrina, G. Simonneau, et al. 1996. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation. Transplantation. 61:1757-1762.
56. Zeevi, A., M. Pavlakis, K. Spichty, S. Chang, A. Iacono, J. Dauber, G. Burckart, K. McCurry, R. Keenan, W. Grgurich, et al. 2001. Prediction of rejection in lung transplantation. Transplant. Proc. 33:291-292.
57. Agostini, C., F. Calabrese, F. Rea, M. Facco, A. Tosoni, M. Loy, G. Binotto, M. Valente, L. Trentin, and G. Semenzato. 2001. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am. J. Pathol. 158:1703-1711.
58. Cunningham, D.A., M.J. Dunn, M.H. Yacoub, and M.L. Rose. 1994. Local production of cytokines in the human cardiac allograft. A sequential study. Transplantation. 57:1333-1337.
59. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 α, interleukin-8 and RANTES. Eur. J. Immunol. 25:751-756.
60. + T cells: Potential roles in inflammation. J. Immunol. 158:3046-3053.